Brief: Themis Medicare Files Petition Against FDA Order Banning Manufacture Of Key Product
July 12 (Reuters) - Themis Medicare Ltd THEM.NS :
* SAYS RECEIVED LETTER FROM FDA AUTHORITIES DIRECTING, INTER
ALIA,
NOT TO MANUFACTURE KEY PRODUCT TILL DECIDING OF MATTER
* THEMIS MEDICARE -HAS FILED A WRIT PETITION IN DELHI HIGH
COURT
Source text for Eikon: ID:nBSE1f7BJR
Further company coverage: THEM.NS
(Reuters.Briefs@thomsonreuters.com)
Recent news on Themis Medicare
See all newsBrief: Themis Medicare Gets Tax Demand Of 41.8 Million Rupees
Brief: Themis Medicare Announces Amalgamation Of Gujarat Themis Biosyn With Co
India's Themis Medicare hits record high on Q1 profit jump
Brief: Themis Medicare June-Qtr Consol Net Profit 246.8 Mln Rupees
India's Themis Medicare hits record high